UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs

The Journal of biological chemistry, 2003-04, Vol.278 (14), p.11979-11984

2003

Volltextzugriff (PDF)

Inhibition of a Mitotic Motor Protein: Where, How, and Conformational Consequences

Journal of molecular biology, 2004-01, Vol.335 (2), p.547-554

2004

Volltextzugriff (PDF)

Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation

The Journal of biological chemistry, 2017-10, Vol.292 (43), p.17963-17974

2017

Volltextzugriff (PDF)

Host Cell Factor Requirement for Hepatitis C Virus Enzyme Maturation

Proceedings of the National Academy of Sciences - PNAS, 2001-11, Vol.98 (24), p.13931-13935

2001

Volltextzugriff (PDF)

Fragment Based Drug Design: Tools, Practical Approaches, and Examples

Kuo, Lawrence C

1, 2011

Volltextzugriff (PDF)

Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP

Bioorganic & medicinal chemistry letters, 2007-10, Vol.17 (20), p.5677-5682

2007

Volltextzugriff (PDF)

Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors

Bioorganic & medicinal chemistry letters, 2007-11, Vol.17 (21), p.5989-5994

2007

Volltextzugriff (PDF)

Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution

Protein science, 2011-04, Vol.20 (4), p.670-683

2011

Volltextzugriff (PDF)

How to Avoid Rediscovering the Known

Methods in Enzymology, 2011, Vol.493, p.159-168

Kuo, Lawrence C.

2011

Volltextzugriff (PDF)

Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors

Bioorganic & medicinal chemistry letters, 2011-08, Vol.21 (16), p.4762-4767

2011

Volltextzugriff (PDF)

Only a Small Fraction of Purified Hepatitis C RNA-Dependent RNA Polymerase Is Catalytically Competent: Implications for Viral Replication and in Vitro Assays

Biochemistry (Easton), 2000-07, Vol.39 (28), p.8243-8249

2000

Volltextzugriff (PDF)

Electron Density Guided Fragment-Based Lead Discovery of Ketohexokinase Inhibitors

Journal of medicinal chemistry, 2010-11, Vol.53 (22), p.7979-7991

2010

Volltextzugriff (PDF)

Fragment-based drug design - tools, practical approaches, and examples. Preface

Methods in enzymology, 2011, Vol.493, p.xxi-xxii

Kuo, Lawrence C

2011

Volltextzugriff (PDF)

Viral polymerases and related proteins

Carroll, Steven S

1996

Volltextzugriff (PDF)

Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 Å resolution

Acta crystallographica. Section D, Biological crystallography., 2003-10, Vol.59 (10), p.1725-1730

2003

Volltextzugriff (PDF)

Identification of MK-944a: A Second Clinical Candidate from the Hydroxylaminepentanamide Isostere Series of HIV Protease Inhibitors

Journal of medicinal chemistry, 2000-09, Vol.43 (18), p.3386-3399

2000

Volltextzugriff (PDF)

Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP

Bioorganic & medicinal chemistry letters, 2006-04, Vol.16 (7), p.1775-1779

2006

Volltextzugriff (PDF)

Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP

Bioorganic & medicinal chemistry letters, 2006-06, Vol.16 (12), p.3175-3179

2006

Volltextzugriff (PDF)

Screening and characterization of human monoglyceride lipase active site inhibitors using orthogonal binding and functional assays

Journal of biomolecular screening, 2012-06, Vol.17 (5), p.629-640

2012

Volltextzugriff (PDF)

Discovery and Evaluation of Potent P1 Aryl Heterocycle-Based Thrombin Inhibitors

Journal of medicinal chemistry, 2004-06, Vol.47 (12), p.2995-3008

2004

Volltextzugriff (PDF)

3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6

Bioorganic & medicinal chemistry letters, 2006-12, Vol.16 (23), p.6049-6053

2006

Volltextzugriff (PDF)

Kinesin spindle protein (KSP) inhibitors. Part 3: Synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility

Bioorganic & medicinal chemistry letters, 2006-04, Vol.16 (7), p.1780-1783

2006

Volltextzugriff (PDF)

Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase. Implication for inhibitor specificity

The Journal of biological chemistry, 2002-10, Vol.277 (41), p.38797-38802

2002

Volltextzugriff (PDF)

Dissociation and association of the HIV-1 protease dimer subunits: Equilibria and rates

Biochemistry (Easton), 1994-01, Vol.33 (1), p.98-105

1994

Volltextzugriff (PDF)

1 – 25 von 352

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(330)
Mit Volltextzugriff
(320)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(352)
Chinesisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs

Inhibition of a Mitotic Motor Protein: Where, How, and Conformational Consequences

Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation

Host Cell Factor Requirement for Hepatitis C Virus Enzyme Maturation

Fragment Based Drug Design: Tools, Practical Approaches, and Examples

Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP

Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors

Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution

How to Avoid Rediscovering the Known

Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2S)-4-(2,5-Difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer

Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors

Only a Small Fraction of Purified Hepatitis C RNA-Dependent RNA Polymerase Is Catalytically Competent: Implications for Viral Replication and in Vitro Assays

Electron Density Guided Fragment-Based Lead Discovery of Ketohexokinase Inhibitors

Fragment-based drug design - tools, practical approaches, and examples. Preface

Viral polymerases and related proteins

Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 Å resolution

Identification of MK-944a: A Second Clinical Candidate from the Hydroxylaminepentanamide Isostere Series of HIV Protease Inhibitors

Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP

Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP

Screening and characterization of human monoglyceride lipase active site inhibitors using orthogonal binding and functional assays

Discovery and Evaluation of Potent P1 Aryl Heterocycle-Based Thrombin Inhibitors

3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6

Kinesin spindle protein (KSP) inhibitors. Part 3: Synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility

Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase. Implication for inhibitor specificity

Dissociation and association of the HIV-1 protease dimer subunits: Equilibria and rates

Suchergebnisse filtern